NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CureApp

CureApp

Private
TokyoHealthcare & Life Scienceshttps://cureapp.co.jp/

Last Round

Series G

Aug 16, 2022

Est. Valuation

$460M

Total Funding Raised

$109.93M

Company Overview

CureApp is a digital health company that develops evidence-based digital therapeutics (DTx) and mobile health programs to treat lifestyle-related diseases through personalized, app-based interventions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Platform-as-a-Service, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxprescription digital therapeuticsdigital healthchronic disease managementmedical softwarebehavioral interventionpatient adherencedigital health platformremote patient monitoringRPMlifestyle modificationhealth-techclinical-grade softwareapp-based therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureApp Comparables

Compare CureApp with similar companies based on industry and business-model similarity.

CureApp comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SUSMED, Inc.
80%
Click Therapeutics
77%
Otsuka Holdings
76%

CureApp Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series GAug 16, 2022
Series DMar 12, 2021
Series CJul 5, 2019
Series BFeb 26, 2018
Series AFeb 7, 2017
Seed
Oct 6, 2015

CureApp Investors

Notable investors and investment history

CureApp investors
InvestorRounds
Mori Trust Co., Ltd.Series C
INTAGE HOLDINGS Inc.Series C
Saisei VenturesSeries D
ITOCHU Technology VenturesSeries C, Series B, Series D
Shinsei Impact Investment LimitedSeries D
Keio Innovation InitiativeSeries C, Series A, Series B
Mizuho CapitalSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    Launched DTx-BASE to help companies develop therapeutic apps.

  • Aug 16, 2022

    $52M round led by The Carlyle Group.

CureApp Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CureApp Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CureApp's valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range60
Year Founded2014
Last FundingAug 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.